Skip links

PGT-A – Preimplantation Genetic Testing for Aneuploidies

PGT-A – Preimplantation Genetic Testing for Aneuploidies



A genetic test that screen embryos for chromosome abnormalities prior to transfer and improve success rate of in vitro fertilization (IVF) treatment.

Request Information


Embryos with abnormal chromosomes (also called aneuploid embryos) normally result in a miscarriage or may lead to the birth of a child with genetic condition.

PGT-A is particularly important for female patients over age 35, as the risk of chromosomal abnormality increases with maternal age.

PGT-A (also known as PGS, Preimplantation Genetic Screening) is a genetic testing, performed on an in vitro fertilized embryo- before the  embryo gets transferred, to screen the embryo’s genetic health, so that your physician could select the best embryo for implantation and increased the chance of a successful pregnancy.

Moreover, PGT-A can greatly reduce the chances of a patient having multiple pregnancies by providing information to select the optimal embryo for Single Embryo Transfer.

This test is recommended for people who:

  • Advanced maternal age.
  • Couples with infertility concerns.
  • Couples with recurrent miscarriages.
  • Couples with many failed IVF cycles.
  • Couples with a family history of chromosomal abnormalities.
  • Couples undergoing IVF treatment for other reasons.

PGT-A can also be done in conjunction with MIRA to increase the chance of implantation: Choose the best embryo transfer at the right time!

Find out more for MIRA test

Advantages of GGA PGT-A in Reproductive Medicine

Why Choose GGA PGT-A?



Download PDF

Related paper study

Click to study